Majedie Asset Management’s Zimmer Biomet ZBH Stock Holding History

Majedie Asset Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$40.3M	Buy	315,580 +117,551	+59%	+$14.2M	3.3%	6
2021 Q4	$24.5M	Sell	198,029 -1,670	-0.8%	-$219K	1.86%	17
2021 Q3	$28.4M	Buy	199,699 +36,249	+22%	+$5.33M	2.15%	11
2021 Q2	$25.5M	Sell	163,450 -3,985	-2%	-$646K	1.68%	14
2021 Q1	$26M	Buy	167,435 +10,883	+7%	+$1.69M	1.89%	12
2020 Q4	$23.4M	Buy	156,552 +6,645	+4%	+$939K	1.8%	17
2020 Q3	$19.8M	Buy	149,907 +1,854	+1%	+$242K	1.47%	16
2020 Q2	$17.2M	Buy	148,053 +81,293	+122%	+$9.37M	1.31%	16
2020 Q1	$6.57M	Sell	66,760 -23,910	-26%	-$3.13M	0.61%	33
2019 Q4	$13.2M	Buy	90,670 +29,769	+49%	+$4.11M	0.96%	24
2019 Q3	$8.12M	Buy	+60,901	New	+$7.87M	0.69%	29

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Majedie Asset Management's ZBH Position: Q1 2022 in Review

Majedie Asset Management increased its Zimmer Biomet (ZBH) stake by 59% in Q1 2022, buying an estimated $14.2M and bringing the position to 315,580 shares worth $40.3M. The position accounts for 3.3% of the portfolio, ranked #6.

Majedie Asset Management first reported a position in ZBH in Q3 2019 and has held it in 11 quarters since. 977 funds tracked by Wall St. Rank hold ZBH as of Q1 2022.

Majedie Asset Management held 315,580 shares of Zimmer Biomet worth $40.3M as of Q1 2022.
Majedie Asset Management bought 117,551 Zimmer Biomet shares in Q1 2022, an estimated $14.2M.
Zimmer Biomet made up 3.3% of Majedie Asset Management's portfolio in Q1 2022, its #6 holding.
Majedie Asset Management first reported a position in Zimmer Biomet in Q3 2019 and has held it in 11 quarters since.
977 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2022.

Based on Majedie Asset Management's 13F filing for Q1 2022, filed 16 May 2022.